国际辅助生殖技术监测委员会世界报告:2015年和2016年辅助生殖技术
该报告回顾性调查了2015年74个国家3103家及2016年79个国家3249家辅助生殖技术诊所的数据,报告了2015年2358239个周期、548652名婴儿出生,2016年2807963个周期、647188名婴儿出生;2015至2016年辅助生殖技术利用率和每周期出生数增加,多胎分娩率下降。
要点
- 2015年报告周期2358239个、婴儿548652名;2016年报告周期2807963个、婴儿647188名。
- 2015年和2016年冻融胚胎移植周期分别占所有胚胎移植的47.0%和51.9%。
- 新鲜自体周期单胚胎移植比例从2015年42.1%升至2016年44.0%,双胎分娩率从16.0%降至14.7%,三胎率从0.6%降至0.4%。
核心结论
- 2015年至2016年辅助生殖技术治疗的利用率和每周期出生数增加,多胎分娩减少。
研究设计与样本
- 回顾性横断面调查,2015年74个国家3103家辅助生殖技术诊所、2016年79个国家3249家诊所通过国家和区域登记处提交周期和妊娠结局数据。
主要发现
- 2015年报告2358239个周期、548652名婴儿出生;2016年报告2807963个周期、647188名婴儿出生。
- 2015年估计≥2683677个周期导致>675134名婴儿出生;2016年估计≥3100448个周期导致≥723026名婴儿出生。
- 报告的周期约占全球利用率的80%。
- 2015年和2016年新鲜自体治疗周期中年龄≥40岁的女性分别占27.6%和27.8%。
- 2015年和2016年冻融胚胎移植周期分别占所有胚胎移植的47.0%和51.9%,卵母细胞捐赠周期分别占6.7%和7.1%。
关键数值与推荐
- 2015年和2016年自体取卵周期中卵胞浆内单精子注射分别占57.7%和56.4%。
- 新鲜和冻融胚胎移植的每取卵周期累积分娩率2015年为32.4%、2016年为33.1%。
- 平均移植胚胎数2015年为1.70、2016年为1.69。
- 新鲜自体周期单胚胎移植比例从2015年42.1%增至2016年44.0%,双胎分娩率从16.0%降至14.7%,三胎率从0.6%降至0.4%。
- 冻融胚胎移植自体治疗周期单胚胎移植比例2015年为62.2%、2016年为64.2%,双胎率2015年10.1%、2016年10.0%,三胎率2015年0.3%、2016年0.2%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report utilization, effectiveness, and safety of assisted reproductive technologies in 2015 and 2016. DESIGN: A retrospective, cross-sectional survey of 3,103 assisted reproductive technology clinics in 74 countries in 2015 and 3,249 clinics in 79 countries in 2016 that submitted cycle and pregnancy outcome data through national and regional registries. SETTING: Seventy-nine countries and >3,000 assisted reproductive technology clinics. PATIENT(S): Patients undergoing assisted reproductive technology procedures. INTERVENTION(S): Assisted reproductive technology. MAIN OUTCOME MEASURE(S): Outcomes on country, regional, and global levels. RESULT(S): Reported for 2015: 2,358,239 cycles with 548,652 infants born; for 2016: 2,807,963 cycles with 647,188 infants born. Estimated in 2015, ≥2,683,677 cycles resulted in >675,134 infants; in 2016, ≥3,100,448 cycles resulted in ≥723,026 infants. Reported cycles represent approximately 80% of global utilization. In 2015 and 2016, 27.6% and 27.8%, respectively, of women undergoing fresh autologous treatment cycles were aged ≥40 years. Frozen-thawed embryo transfer (ET) cycles accounted for 47.0% and 51.9%, respectively, of all ETs in 2015 and 2016. Oocyte donation cycles accounted for 6.7% and 7.1% of all ETs in 2015 and 2016. Intracytoplasmic sperm injection was performed in 57.7% and 56.4% of autologous aspiration cycles in 2015 and 2016, respectively. The cumulative delivery rate per aspiration cycle for fresh and frozen-thawed ET was 32.4% in 2015 and 33.1% in 2016, respectively. The average number of transferred embryos was 1.70 in 2015 and 1.69 in 2016. The proportion of single ETs in fresh autologous cycles increased from 42.1% in 2015 to 44.0% in 2016. The twin delivery rate decreased from 16.0% in 2015 to 14.7% in 2016, and the triplet rate decreased from 0.6% in 2015 to 0.4% in 2016. The proportion of single ETs in frozen-thawed ET autologous treatment cycles was 62.2% in 2015 and 64.2% in 2016, with twin and triplet rates of 10.1% and 0.3% in 2015 and 10.0% and 0.2% in 2016, respectively. CONCLUSION(S): Utilization of assisted reproductive technology treatment and births per cycle increased from 2015 to 2016, although multiple births were reduced. An increasing proportion of frozen-thawed ET cycles, continuing wide variation in use of intracytoplasmic sperm injection, and an increase in single ET rates are reported.
引用
- Kupka MS, Chambers GM, Dyer S, et al. International Committee for Monitoring Assisted Reproductive Technology world report: assisted reproductive technology, 2015 and 2016. Fertil Steril. 2024. PMID: 38996903. doi:10.1016/j.fertnstert.2024.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。